Combination Chemotherapy with Methotrexate, Etoposide, and Actinomycin D for High-Risk Gestational Trophoblastic Tumors
- 31 July 2000
- journal article
- clinical trial
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 78 (1), 28-31
- https://doi.org/10.1006/gyno.2000.5813
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Comparison of Chemotherapies with Methotrexate, VP-16 and Actinomycin-D in Low-Risk Gestational Trophoblastic DiseaseGynecologic and Obstetric Investigation, 1998
- The Management of Gestational Trophoblastic Tumors with Etoposide, Methotrexate, and Actinomycin DGynecologic Oncology, 1997
- Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapyAmerican Journal of Obstetrics and Gynecology, 1996
- Alternating weekly chemotherapy with etoposide-methotrexatedactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic diseaseInternational Journal of Gynecology & Obstetrics, 1994
- 5-Day Methotrexate for Women with Metastatic Gestational Trophoblastic DiseaseGynecologic Oncology, 1994
- EMACO in High Risk Gestational Trophoblast Disease ‐ The Australian ExperienceAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1994
- Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989BJOG: An International Journal of Obstetrics and Gynaecology, 1991
- EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT)Gynecologic Oncology, 1988
- Developments in chemotherapy for medium‐ and high‐risk patients with gestational trophoblastic tumours (1979–1984)BJOG: An International Journal of Obstetrics and Gynaecology, 1986
- Anti-tumour activity of the epipodophyllin derivative VP16–213 (etoposide: NSC-141540) in gestational choriocarcinomaEuropean Journal of Cancer (1965), 1980